*Some Market data delayed by 15 mins.

JanOne Inc. Common Stock (NV)

Symbol: JAN (NASDAQ)
2.34 ▲ (9.53%) 0.204

Company Description:
JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company's goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations.

Key Stats
  • Today's Open: $2.14
  • Today's High: $2.36
  • Today's Low: $2.1
  • Today's Volume: 139.58K
  • Yesterday Close: $2.14
  • Yesterday High: $2.2798
  • Yesterday Low: $2.005
  • Yesterday Volume: 191.44K
  • Last Min Volume: 0
  • Last Min High: $2.344
  • Last Min Low: $2.303
  • Last Min VWAP: $0
Company Profile
  • Name: JanOne Inc. Common Stock (NV)
  • Website: https://www.janone.com
  • Listed Date: 1991-11-07
  • Location: LAS VEGAS, NV
  • Market Status: Active
  • CIK Number: 0000862861
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $27.14M
  • Round Lot: 100
  • Outstanding Shares: 12.17M
  • Asset Type: CS
RECENT FILINGS FOR JAN
Filing DateFiling TypeFormat
2024-06-218-KView
2024-06-21424B5View
2024-06-058-K/AView
2024-06-048-KView
2024-05-318-KView
2024-05-23424B5View
2024-05-218-KView
2024-05-068-KView
2024-05-06424B5View
2024-05-0310-QView
2024-04-30S-8View
2024-04-25EFFECTView
2024-04-23CORRESPView
2024-04-23UPLOADView
2024-04-228-KView
2024-04-18S-3View
2024-04-0810-KView
2024-03-29NT 10-KView
2024-03-158-KView
2024-02-288-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.